227
Views
14
CrossRef citations to date
0
Altmetric
Pharmacokinetics

Pharmacokinetics and tissue residues of moxifloxacin in broiler chickens

Pages 251-258 | Accepted 03 Oct 2008, Published online: 17 Apr 2009

References

  • Abd El-Aty , AM and Goudah , A . 2002 . Some pharmacokinetic parameters of pefloxacin in lactating goats . Veterinary Research Communications , 26 : 553 – 561 .
  • Abd El-Aty , AM , Goudah , A , Ismail , M and Shimoda , M . 2005 . Disposition kinetics of difloxacin in rabbit after intravenous and intramuscular injection of dicural . Veterinary Research Communications , 29 : 297 – 304 .
  • Abo El-Sooud , K . 2003 . Influence of albendazole on the disposition kinetics and milk antimicrobial equivalent activity of enrofloxacin in lactating goats . Pharmacological Research , 48 : 389 – 395 .
  • Atef , M , El-Banna , HA , Abd El-Aty , AM and Goudah , A . 2002 . Pharmacokinetics of difloxacin in goats . Deutsche Tierarztliche Wochenschrift , 109 : 320 – 323 .
  • Ball , B . 2000 . Moxifloxacin (Avelox) an 8-methoxyquinolone antibacterial with enhanced potency . International Journal of Clinical Practice , 54 : 329 – 332 .
  • Baohong , J , Sebastein , L , Jerome , R , Aurelie , C , Chantal , T and Vincent , J . 2006 . In vitro and In vivo activities of rifampin, streptomycin, amikacin, moxifloxacin, R207910, linezolid and PA-824 against Mycobacterium ulcerans . Antimicrobial Agents and Chemotherapy , 50 : 1921 – 1926 .
  • Blondeau , JM and Hansen , GT . 2001 . Moxifloxacin: a review of the microbiological, pharmacological, clinical and safety features . Expert Opinion on Pharmacothery , 2 : 317 – 335 .
  • Brown , SA . 1996 . Fluorquinolones in animal health . Journal of Veterinary Pharmacology and Therapeutics , 19 : 1 – 14 .
  • Carceles , CM , Serrano , JM , Marin , P , Escudero , E and Fernandez-Varon , E . 2006 . Pharmacokinetics of moxifloxacin in rabbits after intravenous, subcutaneous and a long-acting poloxamer 407 gel formulation administration . Journal of Veterinary Medicine A , 53 : 300 – 304 .
  • Carceles , CM , Villamayor , L , Escudero , E , Marin , P and Fernandez-Varon , E . 2007 . Pharmacokinetics and milk penetration of moxifloxacin after intramuscular administration to lactating goats . The Veterinary Journal , 173 : 452 – 455 .
  • Cester , C , Schneider , M and Toutain , PL . 1996 . Comparative kinetics of two orally administered fluoroquinolones in dog: enrofloxacin versus marbofloxacin . Revue de Medecine Veterinaire , 147 : 703 – 716 .
  • Craig , AW and Suh , B . 1991 . “ Protein binding and the antibacterial effects. Method for the determination of protein binding ” . In Antibiotics in Laboratory Medicine , 3rd , Edited by: Lorian , V . 367 – 402 . Baltimore, MD : Williams & Wilkins .
  • Dalhoff , A , Petersen , U and Endermann , R . 1996 . In vitro activity of BAY 12-8039, a new 8-methoxyquinolone . Chemotherapy , 42 : 410 – 425 .
  • Drusano , GL , Johnson , DE , Rosen , M and Standiford , HC . 1993 . Pharmacodynamics of a fluoroquinolone antimicrobial agents in a neutropenic rat model of pseudomonas sepsis . Antimicrobial Agents and Chemotherapy , 37 : 483 – 490 .
  • El-Banna , HA and Abo El-Sooud , K . 1998 . Disposition kinetics of ciprofloxacin in lactating goats . Deutsche Tierarztliche Wochenschrift , 105 : 35 – 38 .
  • Fernandez-Varon , E , Bovaira , MJ , Espuny , A , Escudero , E , Vancraeynest , D and Carceles , CM . 2005 . Pharmacokinetic-pharmacodynamic integration of moxifloxacin in rabbits after intravenous, intramuscular and oral administration . Journal of Veterinary Pharmacology and Therapeutics , 27 : 57 – 60 .
  • Fernandez-Varon , E , Villamayor , L , Escudero , E , Espuny , A and Carceles , CM . 2006 . Pharmacokinetics and milk penetration of moxifloxacin after intravenous and subcutaneous administration to lactating goats . The Veterinary Journal , 172 : 302 – 307 .
  • Fernandez-Varon , E , Marin , PE , Escudero , E , Vancraeynest , D and Carceles , CM . 2007 . Pharmacokinetic-pharmacodynamic integration of danofloxacin after intravenous, intramuscular and subcutaneous administration to rabbits . Journal of Veterinary Pharmacology and Therapeutics , 30 : 18 – 24 .
  • Gardner , SY , Davis , JL , Jones , SL , Lafevers , DH , Hoskins , MS , Mcarver , EM and Papich , MG . 2004 . Moxifloxacin pharmacokinetics in horses and disposition into phagocytes after oral dosing . Journal of Veterinary Pharmacology and Therapeutics , 27 : 57 – 60 .
  • Gibaldi , M and Perrier , D . 1982 . Pharmacokinetics , New York : Marcel Dekker .
  • Goudah , A . 2008 . Disposition kinetics of moxifloxacin in lactating ewes . The Veterinary Journal , 78 : 282 – 287 . doi:10·1016/j.tvjl.2007
  • Haritova , AM , Rusenova , NV , Parvanov , PR , Lashev , LD and Fink-Germmels , J . 2006 . Pharmacokinetic-pharmacodynamic modelling of danofloxacin in turkeys . Veterinary Research Communications , 30 : 775 – 789 .
  • Intorre , L , Mengozzi , G , Bertini , S , Bagliacca , M , Luchetti , E and Soldani , G . 1997 . The plasma kinetics and tissue distribution of enrofloxacin and its metabolite ciprofloxacin in the Muscovy duck . Veterinary Research Communications , 21 : 127 – 136 .
  • Kowalski , RP , Dhaliwal , DK , Karenchak , LM , Romanowski , EG , Mah , FS , Ritterband , DC and Gordon , YJ . 2003 . Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates . American Journal of Ophthalmology , 136 : 500 – 505 .
  • Knoll , U , Glunder , G and Kietzmann , M . 1999 . Comparative study of the plasma pharmacokinetics and tissue concentrations of danofloxacin and enrofloxacin in broiler chickens . Journal of Veterinary Pharmacology and Therapeutics , 22 : 239 – 246 .
  • Lam , FC , Hung , CT and Perrier , DG . 1985 . Estimation of variances for harmonic mean half-time . Journal of Pharmaceutical Sciences , 74 : 229 – 231 .
  • Lode , H , Borner , K and Koeppe , P . 1998 . Pharmacodynamics of fluoroquinolones . Clinical Infectious Diseases , 27 : 33 – 39 .
  • Mohan , J , Sastry , KVH , Tyagi , JS , Rao , GS and Singh , RV . 2006 . Residues of fluoroquinolone drugs in the cloacal gland and other tissues of Japanese quail . British Poultry Science , 47 : 83 – 87 .
  • Pant , S , Rao , GS , Sastry , KVH , Tripathy , HC , Jagmohan and Malik , JK . 2005 . Pharmacokinetics and tissue residues of pefloxacin and its metabolite norfloxacin in broiler chickens . British Poultry Science , 46 : 615 – 620 .
  • Shojaee Aliabadi , F , Badrelin , H , Landoni , MF and Lees , P . 2003 . Pharmacokinetics and PK-PD modelling of danofloxacin in camel serum and tissue cage fluids . The Veterinary Journal , 165 : 104 – 118 .
  • Siefert , HM , Kohlsdorfer , C , Steinke , W and Witt , A . 1999a . Pharmacokinetics of the 8-methoxyquinolone, moxifloxacin: tissue distribution in male rats . Journal of Antimicrobial Chemotherapy , 43 ( Suppl. B ) : 61 – 67 .
  • Siefert , HM , Domdey-Bette , A , Henninger , F , Hucke , F , Kohlsdorfer , C , Steinke , W and Stass , HH . 1999b . Pharmacokinetics of the 8-methoxyquinolone, moxifloxacin: a comparison in humans and other mammalian species . Journal of Antimicrobial Chemotherapy , 43 ( Suppl. B ) : 69 – 76 .
  • Spreng , M , Deleforge , J , Thomas , E , Boisrame , B and Drugeon , H . 1995 . Antibacterial activity of marbofloxacin. A new fluoroquinolone for veterinary use against canine and feline isolates . Journal of Veterinary Pharmacology and Therapeutics , 18 : 284 – 289 .
  • Stass , H . 1999 . Absorption and bioavailability of moxifloxacin . Drugs , 58 : 227 – 228 .
  • Stass , H and Kubitza , D . 1999 . Pharmacokinetics and elimination of moxifloxacin after oral and intravenous administration in man . Journal of Antimicrobial Chemotherapy , 43 : 83 – 90 .
  • Stass , H , Dalhoff , A , Kubitza , D and Schuhly , U . 1998 . Pharmacokinetics, safety, and tolerability of ascending single doses of moxifloxacin, a new 8-methoxy quinolone, administered to healthy subjects . Antimicrobial Agents and Chemotherapy , 42 : 2060 – 2065 .
  • Toutain , PL and Bousquet-Melou , A . 2004 . Volumes of distribution . Journal of Veterinary Pharmacology and Therapeutics , 27 : 441 – 453 .
  • Toutain , PL and Lees , P . 2004 . Integration and modeling of pharmacokinetic and pharmacodynamic data to optimize dosage regimens in veterinary medicine . Journal of Veterinary Pharmacology and Therapeutics , 27 : 467 – 477 .
  • Toutain , PL , Delcastillo , JRE and Bousquet-Melou , A . 2002 . The pharmacokinetic-pharmacodynamic approach to a rational dosage regimen for antibiotics . Research in Veterinary Science , 73 : 105 – 114 .
  • Turnidge , J . 1999 . Pharmacokinetics and pharmacodynamics of fluoroquinolones . Drugs , 58 : 29 – 36 .
  • Woodcock , JM , Andrews , JM and Boswell , FJ . 1997 . In vitro activity of BAY 12-8039, a new fluoroquinolone . Antimicrobial Agents and Chemotherapy , 41 : 101 – 106 .
  • Yamaoka , K , Nakagawa , T and Uno , T . 1978 . Statistical moment in pharmacokinetics . Journal of Pharmacokinetics and Biopharmaceutics , 6 : 547 – 558 .
  • Zlotos , G , Bucker , A , Kinzig-Schippers , M , Sorgel , F and Holzgrabe , U . 1998 . Plasma protein binding of gyrase inhibitors . Journal of Pharmaceutical Science , 87 : 215 – 220 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.